Browsing by Author Martínez Yélamos, Sergio

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 20
Issue DateTitleAuthor(s)
2-Oct-2015Acute non compressive myelopathiesCobo Calvo, Álvaro
14-Nov-2014Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patientsMatas Martín, Elisabet; Bau, Laura; Martínez Iniesta, María; Romero Pinel, Lucía María; Mañé Martínez, M. Alba; Cobo Calvo, Álvaro; Martínez Yélamos, Sergio
28-Dec-2020Blood test dynamics in hospitalized COVID-19 patients: Potential utility of D-dimer for pulmonary embolism diagnosisCerdà, Pau; Ribas, Jesús; Iriarte, Adriana; Mora Luján, José María; Torres, Raquel; Río, Belén del; Jofré, Héctor Ignacio; Ruiz, Yolanda; Huguet, Marta; Fuset, Maria Paz; Martínez Yélamos, Sergio; Santos, Salud; Llecha, Núria; Corbella, Xavier; Riera Mestre, Antoni
Nov-2006Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disabilityCasado Ruiz, Virginia; Martínez Yélamos, Sergio; Martínez Yélamos, Antonio; Carmona i Codina, Olga; Alonso, Lucia; Romero Pinel, Lucía María; Moral, Esther; Gubieras, Laura; Arbizu Urdiain, Txomin
1-May-2020Effectiveness of Fingolimod versus Natalizumab as Second-Line Therapy for Relapsing-Remitting Multiple Sclerosis in Spain: Second-Line GATE StudyMeca Lallana, José E.; Ayuso, Teresa; Martínez Yélamos, Sergio; Duran, Carmen; Contreras Martín, Yessica; Herrera Navarro, Nicolás; Pérez Sempere, Angel; Álvarez Cermeño, José C.; Millán Pascual, Jorge; Meca Lallana, Virginia; Romero Sevilla, Raúl; Ricart, Javier
1-Aug-2005Estudio de la demanada de electromiografía en un hospital general básicoMartínez Yélamos, Antonio; Admetlla i Falgueras, Margarita; Huerta Villanueva, Mariano; Jato-de Evan, Mario; Martínez Yélamos, Sergio
27-Oct-2016Expresión del gen de la proteína MxA como biomarcador de respuesta al interferón beta en pacientes con esclerosis múltipleMatas Martín, Elisabet
3-Nov-2010Genética de la esclerosis múltiple: papel del HLA-DRB1 en la susceptibilidad y expresión fenotípicaRomero Pinel, Lucía María
15-Oct-2016Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosisMañé Martínez, M. Alba; Olsson, Bob; Bau, Laura; Matas Martín, Elisabet; Cobo Calvo, Álvaro; Andreasson, Ulf; Blennow, Kaj; Romero Pinel, Lucía María; Martínez Yélamos, Sergio; Zetterberg, Henrik
3-Oct-2013Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large seriesCobo Calvo, Álvaro; Mañé Martínez, M. Alba; Alentorn Palau, Agustí; Bruna, Jordi; Romero Pinel, Lucía María; Martínez Yélamos, Sergio
1-Nov-2020Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral SclerosisAndrés Benito, Pol; Povedano, Mònica; Domínguez, Raúl; Marco, Carla; Colomina Soler, M. J. (María José); López Pérez, Óscar; Santana, Isabel; Baldeiras, Inês; Martínez Yélamos, Sergio; Zerr, Inga; Llorens Torres, Franc; Fernández Irigoyen, Joaquín; Santamaría, Enrique; Ferrer, Isidro (Ferrer Abizanda)
19-Jan-2021Individualización posológica de natalizumab en la esclerosis múltiple remitente recurrenteSantulario Verdú, Laura; Colom Codina, Helena; Martínez Yélamos, Sergio; Bau, Laura; Matas Martín, Elisabet; Romero Pinel, Lucía María; Padulles Zamora, Ariadna; Morandeira-Rego, Francisco; Santacana Juncosa, Eugènia; Padullés Zamora, Núria
30-Oct-2012Infecciones del sistema nervioso central por Listeria monocytogenesMoragas Garrido, Mireia
11-Sep-2009Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in SpainRello, Jordi; Rodríguez, Alejandro; Ibañez, Pedro; Socias, Lorenzo; Cebrian, Javier; Marques, Asunción; Guerrero, José; Ruiz Santana, Sergio; Marquez, Enrique; Nogal Saez, Frutos Del; Álvarez Lerma, Francisco; Martínez Yélamos, Sergio; Ferrer, Miquel; Avellanas, Manuel; Granada, Rosa; Maraví Poma, Enrique; Albert, Patricia; Sierra, Rafael; Vidaur, Loreto; Ortiz, Patricia; Portillo, Isidro Prieto del; Galvan, Beatriz; León Gil, Cristóbal; H1N1 SEMICYUC Working Group
15-Aug-2016Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple SclerosisFernández, O.; Arroyo, R.; Martínez Yélamos, Sergio; Marco, M.; García Merino, J. A.; Muñoz, D.; Merino, E.; Roque, A.
29-Apr-2014MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption studyFox, Robert J.; Cree, Bruce A.C.; Sèze, Jerome De; Gold, Ralf; Hartung, Hans-Peter; Jeffery, Douglas; Kappos, Ludwig; Kaufman, Michael; Montalbán Gairín, Xavier; Weinstock-Guttman, Bianca; Anderson, Britt; Natarajan, Amy; Ticho, Barry; Duda, Petra; Martínez Yélamos, Sergio; RESTORE
1-Jul-2017Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: cohort study of a 40-year clinical experience at a tertiary referral center in BarcelonaMañá Rey, Juan Ma.; Rubio-Rivas, Manuel; Villalba, Nadia; Marcoval Caus, Joaquim; Iriarte, Adriana; Molina Molina, María; Llatjós, Roger; Garcia Garcia, Olga; Martínez Yélamos, Sergio; Vicens-Zygmunt, Vanesa; Gámez, Cristina; Pujol Farriols, Ramon; Corbella, Xavier
19-Jan-2017Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple SclerosisHauser, Stephen L.; Bar-Or, Amit; Comi, Giancarlo; Giovannoni, Gavin; Hartung, Hans-Peter; Hemmer, Bernhard; Lublin, Fred; Montalbán Gairín, Xavier; Rammohan, Kottil W.; Selmaj, Krzysztof; Traboulsee, Anthony; Wolinsky, Jerry S.; Arnold, Douglas L.; Klingelschmitt, Gaelle; Masterman, Donna; Fontoura, Paulo; Belachew, Shibeshih; Chin, Peter; Mairon, Nicole; Garren, Hideki; Kappos, Ludwig; Martínez Yélamos, Sergio; OPERA I; OPERA II Clinical Investigators
16-May-2003Paraparesia transitoria como manifestación de una estenosis carotídea izquierdaBruna, Jordi; Escrig-Avellaneda, Ana; Romero Pinel, Lucía María; Jato-de Evan, Mario; Martínez Yélamos, Sergio; Rubio Borrego, Francisco Ramón
1-Oct-2018The Cytotoxicity of Epsilon toxin from Clostridium perfringens on lymphocytes is mediated by MAL protein expressionBlanch Lozano, Marta; Dorca Arévalo, Jonatan; Not, Anna; Cases, Mercè; Gómez de Aranda, Inmaculada; Martínez Yélamos, Antonio; Martínez Yélamos, Sergio; Solsona Sancho, Carles; Blasi Cabús, Joan